Viridian Therapeutics
VRDN
VRDN
138 hedge funds and large institutions have $906M invested in Viridian Therapeutics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 70 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $1.24B → $906M (-$338M)
42% less call options, than puts
Call options by funds: $3.99M | Put options by funds: $6.92M
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
138
Holding in Top 10
1
Calls
$3.99M
Puts
$6.92M
Top Buyers
| 1 | +$21M | |
| 2 | +$12.5M | |
| 3 | +$11.7M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.11M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$8.01M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$26.3M | |
| 3 | -$22.3M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$12.3M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.9M |